Yair Schneid Reports 2.46M Share Stake in ReShape Lifesciences

TL;DR

**Yair Schneid just disclosed a 2.46M share position in ReShape Lifesciences.**

AI Summary

Yair Schneid, an individual investor, reported beneficial ownership of 2,461,000 shares of ReShape Lifesciences Inc. common stock as of January 5, 2024. This represents a significant stake, giving Schneid sole voting and dispositive power over these shares. For current or prospective shareholders, this filing indicates a substantial individual investment in ReShape Lifesciences, potentially signaling confidence in the company's future, or at least a notable position by a single investor.

Why It Matters

This filing reveals a large individual investor, Yair Schneid, holds a significant portion of ReShape Lifesciences, which could influence future corporate decisions or signal a belief in the company's value.

Risk Assessment

Risk Level: low — This filing is a standard disclosure of beneficial ownership and does not inherently introduce new risks, but rather provides transparency.

Analyst Insight

An investor should note this significant individual ownership as a data point, but further research into Yair Schneid's investment history and ReShape Lifesciences' fundamentals would be necessary before making any investment decisions.

Key Numbers

• 2,461,000 Shares — Beneficially Owned Shares (The total number of ReShape Lifesciences common stock shares Yair Schneid reported owning.)
• January 5, 2024 — Date of Event (The specific date that triggered the requirement for this SC 13G filing.)
• $0.001 — Par Value Per Share (The stated par value of ReShape Lifesciences Inc. common stock.)

Key Players & Entities

• Yair Schneid (person) — reporting person, beneficial owner of shares
• ReShape Lifesciences Inc. (company) — the issuer of the securities
• 2,461,000 Shares (dollar_amount) — number of shares beneficially owned by Yair Schneid

Forward-Looking Statements

• Yair Schneid will maintain a significant stake in ReShape Lifesciences Inc. for the foreseeable future. (Yair Schneid) — medium confidence, target: 2025-01-01

FAQ

Key Financial Figures

• $0.001 — INC. (Name of Issuer) COMMON STOCK, $0.001 PAR VALUE PER SHARE (Title of Class o

Filing Documents

• ea191693-13gschneid_reshape.htm (SC 13G) — 45KB
• 0001213900-24-003832.txt ( ) — 46KB

(a)

ITEM 1 (a) NAME OF ISSUER: Reshape Lifesciences Inc.

(b)

ITEM 1 (b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: 1001 Calle Amanecer, San Clemente, CA 92673

(a)

ITEM 2 (a) NAME OF PERSON FILING: Yair Schneid

(b)

ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 1 Wood Lane, Suffern, NY 10901

(c)

ITEM 2 (c) CITIZENSHIP: USA

(d)

ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Shares, $0.001 par value per share

(e)

ITEM 2 (e) CUSIP NUMBER: 76090R101

IF

ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B): Not applicable

OWNERSHIP

ITEM 4 OWNERSHIP (a) AMOUNT BENEFICIALLY OWNED: 2,461,000 Shares (1) (b) PERCENT OF CLASS: 10.525% (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: (i) SOLE POWER TO VOTE OR DIRECT THE VOTE 2,461,000 Shares (1) (ii) SHARED POWER TO VOTE OR DIRECT THE VOTE 0 Shares (iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 2,461,000 Shares (1) (iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 0 Shares CUSIP No. 76090R101 13G Page 4 of 5 Pages

OWNERSHIP

ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable

OWNERSHIP

ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable

IDENTIFICATION AND CLASSIFICATION OF

ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable

IDENTIFICATION

ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP Not applicable

NOTICE

ITEM 9 NOTICE OF DISSOLUTION OF GROUP Not applicable CUSIP No. 76090R101 13G Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 16, 2024 (Date) /s/ Yair Schneid (Signature) Yair Schneid (Name/Title)

View Full Filing

View this SC 13G filing on SEC EDGAR